Loading, Please Wait...
-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess International Theater --
-- Corporate Booth to Highlight Company’s CDMO Service Offerings and State-of-the-Art Clinical and Commercial Biomanufacturing Capabilities --
TUSTIN, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at the upcoming 2019 BIO International Convention. Company management will participate in a variety of convention activities including presentations, panels and executive interviews related to the CDMO industry within the BioProcess International (BPI) Theater, as well as booth presentations and hospitality events within the exhibit hall. BIO 2019 is being held June 3-6, 2019 in Philadelphia, PA.
Details of Avid’s activities at BIO 2019 are as follows:
For more information on the BIO International Convention, please visit: http://convention.bio.org/.
About Avid Bioservices, Inc.
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. www.avidbio.com
Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 firstname.lastname@example.org Tim Brons (Media) Vida Strategic Partners 415-675-7402 email@example.com